🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
05/09/2007 0,3626 USD
06/06/2007 0,3626 USD
07/03/2007 0,3626 USD
06/12/2006 0,3626 USD
30/08/2006 0,3626 USD
31/05/2006 0,3626 USD
08/03/2006 0,3626 USD
30/11/2005 0,3626 USD
31/08/2005 0,3626 USD
01/06/2005 0,3626 USD
02/03/2005 0,3626 USD
01/12/2004 0,3626 USD
01/09/2004 0,3626 USD
02/06/2004 0,3531 USD
03/03/2004 0,3531 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/03/2006 33,16 33,65 33,12 33,51 +0,46% 1,58% 9.508.190
01/03/2006 33,44 33,55 33,12 33,36 +0,29% 1,28% 8.017.305
28/02/2006 33,48 33,67 33,26 33,26 -1,41% 1,23% 8.932.209
27/02/2006 33,42 33,96 33,42 33,74 +0,74% 1,63% 8.530.091
24/02/2006 33,91 33,91 33,40 33,49 -0,88% 1,52% 6.843.230
23/02/2006 33,92 34,06 33,67 33,79 -1,42% 1,15% 11.021.082
22/02/2006 34,17 34,59 33,87 34,27 +0,93% 2,09% 12.557.555
21/02/2006 34,85 34,97 33,85 33,96 -1,28% 3,23% 10.293.351
17/02/2006 34,33 34,41 33,89 34,40 +0,19% 1,50% 12.301.005
16/02/2006 33,40 34,43 33,38 34,33 +1,96% 3,14% 12.915.447
15/02/2006 33,00 33,68 33,00 33,67 +1,79% 2,08% 13.410.942
14/02/2006 32,93 33,13 32,78 33,08 +1,05% 1,07% 6.944.886
13/02/2006 32,75 33,10 32,57 32,74 +0,00% 1,63% 5.998.438
10/02/2006 32,16 32,82 32,12 32,74 -0,09% 2,20% 7.591.083
09/02/2006 32,90 33,11 32,73 32,77 +0,15% 1,16% 9.022.651
08/02/2006 32,35 32,90 32,10 32,72 +1,78% 2,48% 9.797.123
07/02/2006 32,16 32,82 32,02 32,15 -0,41% 2,49% 7.069.598
06/02/2006 32,67 32,72 32,19 32,28 -1,63% 1,61% 7.084.794
03/02/2006 32,92 33,05 32,27 32,81 +1,69% 2,38% 10.910.099
02/02/2006 32,97 33,14 32,16 32,27 -2,42% 2,98% 11.172.099
01/02/2006 32,70 33,15 32,63 33,07 +0,46% 1,58% 9.140.132
31/01/2006 33,27 33,28 32,81 32,92 +0,12% 1,41% 15.699.878
30/01/2006 32,83 33,06 32,50 32,88 -0,69% 1,71% 10.537.116
27/01/2006 32,25 33,25 32,17 33,11 +2,21% 3,37% 11.474.971
26/01/2006 31,81 32,49 31,79 32,40 +2,29% 2,19% 11.606.810
25/01/2006 31,20 31,72 31,06 31,67 +1,25% 2,11% 8.512.170
24/01/2006 31,23 31,50 31,12 31,28 -0,15% 1,22% 8.081.128
23/01/2006 31,62 31,69 31,26 31,33 -1,26% 1,36% 8.142.646
20/01/2006 31,79 31,90 31,50 31,73 -0,21% 1,26% 10.625.777
19/01/2006 31,83 32,09 31,70 31,79 +0,88% 1,23% 9.769.875